Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02556463
Recruitment Status : Terminated (Company strategy)
First Posted : September 22, 2015
Last Update Posted : December 19, 2018
Sponsor:
Information provided by (Responsible Party):
MedImmune LLC